| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Ludwig Institute for Cancer Research, Brussels Branch and Cellular Genetics Unit, Université Catholique de Louvain, Brussels, Belgium; and
Department of Urology, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium
By stimulating blood lymphocytes with autologous bladder carcinoma cells that had been transfected with B7-1, we obtained a panel of CTL clones which lyse specifically the bladder tumor cells in an MHC class I-restricted fashion. Based on inhibition with anti-HLA Abs and the recognition of allogeneic tumor cells, we could distribute our clones in three groups that recognized three distinct Ags. We characterized one of these Ags by screening a cDNA library prepared with the RNA from this bladder tumor line. This new tumor Ag is a peptide presented by HLA-B4403 molecules. It is produced by a point mutation in a gene that is recorded in databases under the name KIAA0205, is ubiquitously expressed, and whose function is unknown. We also found this mutation in the tumor sample that was originally resected from this patient, but the mutation was not found in the 100 or more independent tumors of various histologic types that were tested. This report is the first to describe the isolation of CTL clones directed against human bladder cancer and the molecular characterization of a bladder tumor Ag.
This article has been cited by other articles:
|
|
 |
|
  M. Sensi and A. Anichini Unique Tumor Antigens: Evidence for Immune Control of Genome Integrity and Immunogenic Targets for T Cell-Mediated Patient-Specific Immunotherapy Clin. Cancer Res., September 1, 2006; 12(17): 5023 - 5032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Grube, K. Rezvani, A. Wiestner, H. Fujiwara, G. Sconocchia, J. J. Melenhorst, N. Hensel, G. E. Marti, L. W. Kwak, W. Wilson, et al. Autoreactive, Cytotoxic T Lymphocytes Specific for Peptides Derived from Normal B-Cell Differentiation Antigens in Healthy Individuals and Patients with B-Cell Malignancies Clin. Cancer Res., February 1, 2004; 10(3): 1047 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chopin, R. Barei-Moniri, P. Maille, M.-A. Le Frere-Belda, B. Muscatelli-Groux, N. Merendino, L. Lecerf, A. Stoppacciaro, and F. Velotti Human Urinary Bladder Transitional Cell Carcinomas Acquire the Functional Fas Ligand during Tumor Progression Am. J. Pathol., April 1, 2003; 162(4): 1139 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-i. Hanada, D. M. Perry-Lalley, G. A. Ohnmacht, M. P. Bettinotti, and J. C. Yang Identification of Fibroblast Growth Factor-5 as an Overexpressed Antigen in Multiple Human Adenocarcinomas Cancer Res., July 1, 2001; 61(14): 5511 - 5516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Probst-Kepper, V. Stroobant, R. Kridel, B. Gaugler, C. Landry, F. Brasseur, J.-P. Cosyns, B. Weynand, T. Boon, and B. J. Van den Eynde An Alternative Open Reading Frame of the Human Macrophage Colony-stimulating Factor Gene Is Independently Translated and Codes for an Antigenic Peptide of 14 Amino Acids Recognized by Tumor-infiltrating CD8 T Lymphocytes J. Exp. Med., May 21, 2001; 193(10): 1189 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Gala, S. Loric, Y. Guiot, S. R. Denmeade, A. Gady, F. Brasseur, M. Heusterspreute, P. Eschwège, Philippe De Nayer, P. Van Cangh, et al. Expression of Prostate-specific Membrane Antigen in Transitional Cell Carcinoma of the Bladder: Prognostic Value? Clin. Cancer Res., October 1, 2000; 6(10): 4049 - 4054. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Heidecker, F. Brasseur, M. Probst-Kepper, M. Gueguen, T. Boon, and B. J. Van den Eynde Cytolytic T Lymphocytes Raised Against a Human Bladder Carcinoma Recognize an Antigen Encoded by Gene MAGE-A12 J. Immunol., June 1, 2000; 164(11): 6041 - 6045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Van den Eynde, B. Gaugler, M. Probst-Kepper, L. Michaux, O. Devuyst, F. Lorge, P. Weynants, and T. Boon A New Antigen Recognized by Cytolytic T Lymphocytes on a Human Kidney Tumor Results from Reverse Strand Transcription J. Exp. Med., December 20, 1999; 190(12): 1793 - 1800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.G.S. Buggins, N. Lea, J. Gaken, D. Darling, F. Farzaneh, G.J. Mufti, and W.J.R. Hirst Effect of Costimulation and the Microenvironment on Antigen Presentation by Leukemic Cells Blood, November 15, 1999; 94(10): 3479 - 3490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bilsborough, A. Van Pel, C. Uyttenhove, T. Boon, and B. J. Van den Eynde Identification of a Second Major Tumor-Specific Antigen Recognized by CTLs on Mouse Mastocytoma P815 J. Immunol., March 15, 1999; 162(6): 3534 - 3540. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
